Abstract
Preclinical Development and Characterization of Humanized Anti-CD72 Nanobody Chimeric Antigen Receptor T Cells for B Cell Malignancies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jtct.2023.12.226
Copy DOIJournal: Transplantation and Cellular Therapy | Publication Date: Feb 1, 2024 |
Preclinical Development and Characterization of Humanized Anti-CD72 Nanobody Chimeric Antigen Receptor T Cells for B Cell Malignancies
Join us for a 30 min session where you can share your feedback and ask us any queries you have